Vetter M - Search Results

1

Management of Patients with Hypersensitivity to Platinum Salts and Taxane in Gynecological Cancers: A Cross-Sectional Study by the European Network of Young Gynaecologic Oncologists (ENYGO).

Zwimpfer TA, Bilir E, Gasimli K, Cokan A, Bizzarri N, Razumova Z, Kacperczyk-Bartnik J, Nikolova T, Pletnev A, Kahramanoglu I, Shushkevich A, Strojna A, Theofanakis C, Cicakova T, Vetter M, Montavon C, Morgan G, Heinzelmann-Schwarz V. Zwimpfer TA, et al. Among authors: vetter m. Cancers (Basel). 2024 Mar 14;16(6):1155. doi: 10.3390/cancers16061155. Cancers (Basel). 2024. PMID: 38539490 Free PMC article.

2

Hormone Receptor Expression in Primary and Recurrent High-Grade Serous Ovarian Cancer and Its Implications in Early Maintenance Treatment.

Vetter M, Stadlmann S, Bischof E, Georgescu Margarint EL, Schötzau A, Singer G, Heinzelmann-Schwarz V, Montavon C. Vetter M, et al. Int J Mol Sci. 2022 Nov 17;23(22):14242. doi: 10.3390/ijms232214242. Int J Mol Sci. 2022. PMID: 36430718 Free PMC article.

3

Upfront Taxane Could Be Superior to Pegylated Liposomal Doxorubicin (PLD): A Retrospective Real-World Analysis of Treatment Sequence Taxane-PLD versus PLD-Taxane in Patients with Metastatic Breast Cancer.

Wallrabenstein T, Oseledchyk A, Daetwyler E, Rochlitz C, Vetter M. Wallrabenstein T, et al. Among authors: vetter m. Cancers (Basel). 2023 Oct 12;15(20):4953. doi: 10.3390/cancers15204953. Cancers (Basel). 2023. PMID: 37894320 Free PMC article.

4

Desensitization in patients with hypersensitivity to platinum and taxane in gynecological cancers.

Zwimpfer TA, Scherer K, Schötzau A, Heinzelmann-Schwarz V, Hartmann K, Vetter M, Montavon C. Zwimpfer TA, et al. Among authors: vetter m. Cancer Med. 2024 Jan;13(1):e6840. doi: 10.1002/cam4.6840. Epub 2023 Dec 22. Cancer Med. 2024. PMID: 38140783 Free PMC article.

5

Prognostic Importance of Axillary Lymph Node Response to Neoadjuvant Systemic Therapy on Axillary Surgery in Breast Cancer-A Single Center Experience.

Grašič Kuhar C, Geiger J, Schwab FD, Heinzelmann-Schwartz V, Vetter M, Weber WP, Kurzeder C. Grašič Kuhar C, et al. Among authors: vetter m. Cancers (Basel). 2024 Mar 27;16(7):1306. doi: 10.3390/cancers16071306. Cancers (Basel). 2024. PMID: 38610984 Free PMC article.

6

Therapeutic approaches in patients with bone metastasis due to endometrial carcinoma - A systematic review.

Heidinger M, Simonnet E, Koh LM, Frey Tirri B, Vetter M. Heidinger M, et al. Among authors: vetter m. J Bone Oncol. 2023 May 15;41:100485. doi: 10.1016/j.jbo.2023.100485. eCollection 2023 Aug. J Bone Oncol. 2023. PMID: 37250286 Free PMC article. Review.

7

Changes in the quality of life of early breast cancer patients and comparison with the normative Slovenian population.

Grasic Kuhar C, Gortnar Cepeda T, Kurzeder C, Vetter M. Grasic Kuhar C, et al. Among authors: vetter m. Radiol Oncol. 2023 Jun 21;57(2):211-219. doi: 10.2478/raon-2023-0019. eCollection 2023 Jun 1. Radiol Oncol. 2023. PMID: 37341200 Free PMC article.

8

Application of a 21-Gene Recurrence Score in a Swiss Single-Center Breast Cancer Population: A Comparative Analysis of Treatment Administration before and after TAILORx.

Chiru ED, Oseledchyk A, Schoetzau A, Kurzeder C, Mosimann R, Vetter M, Grašič Kuhar C. Chiru ED, et al. Among authors: vetter m. Diagnostics (Basel). 2023 Dec 31;14(1):97. doi: 10.3390/diagnostics14010097. Diagnostics (Basel). 2023. PMID: 38201405 Free PMC article.

9

Probabilistic pathway-based multimodal factor analysis.

Immer A, Stark SG, Jacob F, Bonilla X, Thomas T, Kahles A, Goetze S, Milani ES, Wollscheid B; Tumor Profiler Consortium; Rätsch G, Lehmann KV. Immer A, et al. Bioinformatics. 2024 Jun 28;40(Suppl 1):i189-i198. doi: 10.1093/bioinformatics/btae216. Bioinformatics. 2024. PMID: 38940152 Free PMC article.

10

Pegylated liposomal doxorubicin (PLD) in daily practice-A single center experience of treatment with PLD in patients with comorbidities and older patients with metastatic breast cancer.

Wallrabenstein T, Daetwyler E, Oseledchyk A, Rochlitz C, Vetter M. Wallrabenstein T, et al. Among authors: vetter m. Cancer Med. 2023 Jun;12(12):13388-13396. doi: 10.1002/cam4.6041. Epub 2023 May 6. Cancer Med. 2023. PMID: 37148541 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

442 results

Search Page

Filters